EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C29H32ClN5O2 |
| Net Charge | 0 |
| Average Mass | 518.061 |
| Monoisotopic Mass | 517.22445 |
| SMILES | COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1 |
| InChI | InChI=1S/C29H32ClN5O2/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32) |
| InChIKey | DJUFPMUQJKWIJB-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. antiinfective agent A substance used in the prophylaxis or therapy of infectious diseases. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pyronaridine (CHEBI:135951) has role antiinfective agent (CHEBI:35441) |
| pyronaridine (CHEBI:135951) has role antimalarial (CHEBI:38068) |
| pyronaridine (CHEBI:135951) has role antiviral agent (CHEBI:22587) |
| pyronaridine (CHEBI:135951) has role ophthalmology drug (CHEBI:66981) |
| pyronaridine (CHEBI:135951) is a aminoquinoline (CHEBI:36709) |
| INNs | Source |
|---|---|
| pironaridina | WHO MedNet |
| pyronaridine | WHO MedNet |
| Synonyms | Source |
|---|---|
| malaridine | DrugCentral |
| pyronaridine tetraphosphate | DrugCentral |
| Manual Xrefs | Databases |
|---|---|
| 4339 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:74847-35-1 | DrugCentral |
| Citations |
|---|